Evidence map›Paper›PMID 35385219›Full record

ArticleAmerican journal of medical genetics. Part A2022

High prevalence of deleterious mutations in concomitant nonsyndromic cleft and outflow tract heart defects.

Naikhoba C O Munabi, Shady Mikhail, Omar Toubat, Michelle Webb, Allyn Auslander, Pedro A Sanchez-Lara, Zarko Manojlovic, Ryan J Schmidt, David Craig, William P Magee and 1 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Craniofacial and cardiac defects inFrontiers in cell and developmental biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Naikhoba C O MunabiDivision of Plastic and Reconstructive Surgery, Keck School of Medicine of USC, Los Angeles, California, USA.ORCID 0000-0003-2731-837X
Shady MikhailOperation Smile Inc, Virginia Beach, Virginia, USA.
Omar ToubatDivision of Cardiac Surgery, Department of Surgery, Keck School of Medicine of USC, Los Angeles, California, USA.
Michelle WebbDepartment of Translational Genomics, Keck School of Medicine of USC, Los Angeles, California, USA.
Allyn AuslanderOperation Smile Inc, Virginia Beach, Virginia, USA.
Pedro A Sanchez-LaraDepartment of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Zarko ManojlovicDepartment of Translational Genomics, Keck School of Medicine of USC, Los Angeles, California, USA.
Ryan J SchmidtDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
David CraigDepartment of Translational Genomics, Keck School of Medicine of USC, Los Angeles, California, USA.
William P MageeDivision of Plastic and Reconstructive Surgery, Keck School of Medicine of USC, Los Angeles, California, USA.
Subramanyan Ram KumarDivision of Cardiac Surgery, Department of Surgery, Keck School of Medicine of USC, Los Angeles, California, USA.ORCID 0000-0003-1487-4203
Keck Hospital of USC · USChildren's Hospital of Los Angeles · USOperation PAR · USCedars-Sinai Medical Center · USShriners Hospitals for Children - Erie · US

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Southern California Clinical and Translational Science InstituteUL1TR000130 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2012 to 2015
$36.0M
Prox1 and COUP-TFII interactions regulate lymphatic endothelial cell differentiationF30HL154324 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TOUBAT, OMAR · 2020 to 2022
$115k
NCATS NIH HHS UL1 TR000130NCATS NIH HHS UL1 TR001855NHLBI NIH HHS F30 HL154324
6 · The paper itself

Abstract

Our previous work demonstrating enrichment of outflow tract (OFT) congenital heart disease (CHD) in children with cleft lip and/or palate (CL/P) suggests derangements in common underlying developmental pathways. The current pilot study examines the underlying genetics of concomitant nonsyndromic CL/P and OFT CHD phenotype. Of 575 patients who underwent CL/P surgery at Children's Hospital Los Angeles, seven with OFT CHD, negative chromosomal microarray analysis, and no recognizable syndromic association were recruited with their parents (as available). Whole genome sequencing of blood samples paired with whole-blood-based RNA sequencing for probands was performed. A pathogenic or potentially pathogenic variant was identified in 6/7 (85.7%) probands. A total of seven candidate genes were mutated (CHD7, SMARCA4, MED12, APOB, RNF213, SETX, and JAG1). Gene ontology analysis of variants predicted involvement in binding (100%), regulation of transcription (42.9%), and helicase activity (42.9%). Four patients (57.1%) expressed gene variants (CHD7, SMARCA4, MED12, and RNF213) previously involved in the Wnt signaling pathway. Our pilot analysis of a small cohort of patients with combined CL/P and OFT CHD phenotype suggests a potentially significant prevalence of deleterious mutations. In our cohort, an overrepresentation of mutations in molecules associated with Wnt-signaling was found. These variants may represent an expanded phenotypic heterogeneity within known monogenic disease genes or provide novel evidence of shared developmental pathways. The mechanistic implications of these mutations and subsequent developmental derangements resulting in the CL/P and OFT CHD phenotype require further analysis in a larger cohort of patients.

Indexed as

Cleft LipCleft PalateHeart Defects, CongenitalAdenosine TriphosphatasesDNA HelicasesHumansMultifunctional EnzymesMutationNuclear ProteinsPilot ProjectsPrevalenceRNA HelicasesTranscription FactorsUbiquitin-Protein LigasesAdenosine TriphosphatasesDNA HelicasesMultifunctional EnzymesNuclear ProteinsRNA HelicasesRNF213 protein, humanSETX protein, humanSMARCA4 protein, humanTranscription FactorsUbiquitin-Protein Ligasescleft lipcleft palatecongenital heart diseasegenetic syndromewhole genome sequencing

Identifiers

PMID35385219
PMCPMC9197864
OpenAlexW4226043479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.